DE69616554D1 - Sialinsäure-derivate - Google Patents
Sialinsäure-derivateInfo
- Publication number
- DE69616554D1 DE69616554D1 DE69616554T DE69616554T DE69616554D1 DE 69616554 D1 DE69616554 D1 DE 69616554D1 DE 69616554 T DE69616554 T DE 69616554T DE 69616554 T DE69616554 T DE 69616554T DE 69616554 D1 DE69616554 D1 DE 69616554D1
- Authority
- DE
- Germany
- Prior art keywords
- acid derivatives
- sialic acid
- sialic
- derivatives
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15788895 | 1995-06-23 | ||
JP15788995 | 1995-06-23 | ||
PCT/JP1996/001726 WO1997000885A1 (fr) | 1995-06-23 | 1996-06-21 | Derives d'acide sialique |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69616554D1 true DE69616554D1 (de) | 2001-12-06 |
DE69616554T2 DE69616554T2 (de) | 2002-07-11 |
Family
ID=26485180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69616554T Expired - Lifetime DE69616554T2 (de) | 1995-06-23 | 1996-06-21 | Sialinsäure-derivate |
Country Status (7)
Country | Link |
---|---|
US (1) | US6288041B1 (de) |
EP (1) | EP0837070B1 (de) |
JP (1) | JP4094662B2 (de) |
CA (1) | CA2225382C (de) |
DE (1) | DE69616554T2 (de) |
ES (1) | ES2169801T3 (de) |
WO (1) | WO1997000885A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002044324A2 (en) * | 2000-10-06 | 2002-06-06 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
EP1361847A2 (de) * | 2000-10-06 | 2003-11-19 | Xenoport, Inc. | Gallensäurekonjugate zur bereitstellung anhaltender systemischer arneimittelkonzentrationen |
US20020151526A1 (en) * | 2000-10-06 | 2002-10-17 | Gallop Mark A. | Bile-acid prodrugs of L-dopa and their use in the sustained treatment of parkinsonism |
WO2009123877A1 (en) * | 2008-03-21 | 2009-10-08 | Braincells, Inc. | A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257 |
US9119866B2 (en) | 2008-04-08 | 2015-09-01 | Huiru Wang | Glycan-based drugs, therapies and biomarkers |
KR102157141B1 (ko) | 2018-11-27 | 2020-09-17 | 주식회사 파미니티 | 으아리 추출물을 유효 성분으로 포함하는 인지 기능 개선용 조성물 |
KR102172916B1 (ko) | 2018-12-07 | 2020-11-02 | 주식회사 파미니티 | 실크 펩타이드 및 천연 추출물을 포함하는 인지 기능 개선용 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH064671B2 (ja) * | 1985-04-02 | 1994-01-19 | メクト株式会社 | シアル酸誘導体及びその製造方法 |
JPS62209094A (ja) * | 1986-03-10 | 1987-09-14 | Nippon Zoki Pharmaceut Co Ltd | 新規シアル酸誘導体及びその製造方法 |
EP0267297B1 (de) * | 1986-05-12 | 1993-09-15 | Mect Corporation | Sialosylcholesterol, verfahren zu dessen herstellung und arzneimittel zur behandlung von krankheiten des nervensystems |
JPH0592991A (ja) * | 1991-03-27 | 1993-04-16 | Mitsubishi Kasei Corp | チオシアル酸誘導体 |
IT1260156B (it) * | 1992-08-03 | 1996-03-28 | Fidia Spa | Derivati dell'acido neuraminico |
US5783564A (en) * | 1993-12-24 | 1998-07-21 | Mitsubishi Chemical Corporation | Sialic acid derivatives |
TW479061B (en) * | 1993-12-24 | 2002-03-11 | Mitsubishi Chem Corp | Sialic acid derivatives |
-
1996
- 1996-06-21 JP JP50373197A patent/JP4094662B2/ja not_active Expired - Fee Related
- 1996-06-21 ES ES96918876T patent/ES2169801T3/es not_active Expired - Lifetime
- 1996-06-21 US US08/981,240 patent/US6288041B1/en not_active Expired - Lifetime
- 1996-06-21 DE DE69616554T patent/DE69616554T2/de not_active Expired - Lifetime
- 1996-06-21 CA CA002225382A patent/CA2225382C/en not_active Expired - Fee Related
- 1996-06-21 WO PCT/JP1996/001726 patent/WO1997000885A1/ja active IP Right Grant
- 1996-06-21 EP EP96918876A patent/EP0837070B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0837070A1 (de) | 1998-04-22 |
WO1997000885A1 (fr) | 1997-01-09 |
EP0837070A4 (de) | 1999-01-13 |
ES2169801T3 (es) | 2002-07-16 |
CA2225382A1 (en) | 1997-01-09 |
CA2225382C (en) | 2008-06-03 |
JP4094662B2 (ja) | 2008-06-04 |
EP0837070B1 (de) | 2001-10-31 |
DE69616554T2 (de) | 2002-07-11 |
US6288041B1 (en) | 2001-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
DE69522717D1 (de) | Chinazolinderivate | |
DE69611361D1 (de) | Chinazolin-derivate | |
DE69610698D1 (de) | Chinazolin-derivate | |
NO964667D0 (no) | Purin-6-on-derivater | |
ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
DE69606053D1 (de) | Modifizierte fluorsulfonsäure | |
DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
ATA100695A (de) | Prothrombin-derivate | |
ATE240307T1 (de) | Diarylalkenylamin-derivate | |
DE69627830D1 (de) | Pyrazol-derivate | |
NO961404D0 (no) | 4-indolylpiperazinyl-derivater | |
DE59402621D1 (de) | Fluor-trifluormethylbenzoesäure-Derivate | |
DE69616554D1 (de) | Sialinsäure-derivate | |
ATE202093T1 (de) | 4-amino-benzoylguanidin-derivate | |
ATE177102T1 (de) | Chromanderivate | |
DE59610106D1 (de) | Fluorbenzylether-Derivate | |
DE69624122D1 (de) | Aza-anthracyclinone-derivate | |
ATE202088T1 (de) | 4-mercapto-benzoylguanidin-derivate | |
DE69620514D1 (de) | 5-aminoflavon-derivate | |
ATA45796A (de) | Lysin-prolin-derivate | |
DE59606925D1 (de) | 1,6-Naphthyridoncarbonsäurederivate | |
SE9502504D0 (sv) | New amino acid derivatives | |
SE9502487D0 (sv) | New amino acid derivatives | |
SE9502503D0 (sv) | New amino acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |